1928 Circulation October 22, 2013 mental health, functional status, activity limitations,
cancerrelated pain, and cancer-related anxiety) declined moderately to severely in 44%. 5 …

Simple Summary Immunotherapy is increasingly being used to treat solid tumors and
lymphoproliferative diseases. The main classes of drugs are: HER-2-targeted therapies …

BACKGROUND: Recovery of ventricular function during left ventricular assist device (LVAD)
support allowing device explantation occurs infrequently. We explored the hypothesis that …

Oliveira et al Advanced HF Therapy in CCMP 1051 are often younger and consistently
healthier, with significantly less prevalence of diabetes mellitus, hypertension, tobacco …

This report describes an 8-year-old child with acute anthracycline-induced cardiomyopathy
triggered by human herpesvirus 6 and the subsequent implantation of an intracorporeal …

Evolution of ventricular assist devices (VADs) leading to miniaturization has made
intracorporeal implantation in children feasible. Ventricular assist device therapy for …

© 2012 Wiley Periodicals, Inc. Anthracycline treatments are hampered by dose‐related
cardiotoxicity, frequently leading to heart failure (HF) with a very poor prognosis. The authors …

Nonischemic cardiomyopathy can complicate antineoplastic therapy and lead to irreversible
heart failure. We evaluated structural changes at the time of left ventricular assist device …

We describe the case of a teenage girl with anthracycline-induced cardiomyopathy who
received a HeartWare ventricular assist device and underwent successful device …

Anthracyclines are effective antineoplastic drugs, but they are known to be cardiotoxic.
Recovery of cardiac function is rare. A few studies on implantation of a ventricular assist …